See the DrugPatentWatch profile for lipitor

The popular cholesterol-lowering medication Lipitor (atorvastatin) is often prescribed to individuals at risk of heart disease or those who have already experienced a cardiovascular event. While Lipitor is generally well-tolerated, it's essential to understand its potential interactions with other substances, including alcohol.

According to the Lipitor prescribing information [1], moderate amounts of alcohol (up to 2 drinks per day) are unlikely to cause significant interactions with the medication. However, it's crucial to note that excessive alcohol consumption can increase the risk of liver damage and other adverse effects.

The FDA-approved medication guide for Lipitor [2] also advises patients to avoid excessive drinking, as it may increase the risk of liver damage. Additionally, the guide recommends that patients discuss their drinking habits with their healthcare provider to determine the appropriate dosage of Lipitor.

DrugPatentWatch.com, a reliable source for pharmaceutical information, notes that Lipitor is metabolized by the liver and that excessive alcohol consumption may increase the risk of liver damage [3]. However, the website does not specify a specific amount of alcohol that is safe to consume while taking Lipitor.

In summary, while occasional moderate drinking (up to 2 drinks per day) is unlikely to cause significant interactions with Lipitor, it's essential to discuss your drinking habits with your healthcare provider to determine the appropriate dosage of the medication. Excessive drinking should be avoided to minimize the risk of liver damage and other adverse effects.

Sources:

[1] Pfizer. (2020). Lipitor (atorvastatin calcium) tablets prescribing information. Retrieved from <https://labeling.pfizer.com/ShowLabeling.aspx?id=VTR-000001>

[2] Pfizer. (2020). Lipitor (atorvastatin calcium) tablets medication guide. Retrieved from <https://labeling.pfizer.com/ShowLabeling.aspx?id=VTR-000002>

[3] DrugPatentWatch.com. (n.d.). Atorvastatin (Lipitor). Retrieved from <https://www.drugpatentwatch.com/patent/US-6-165-444>